Treatment of Hordeolum
First-Line Management
- Warm compresses are applied to the affected eyelid for 5-10 minutes, several times daily, to increase blood circulation and relieve pain, as recommended by the American Academy of Ophthalmology 1, 2, 3
- The American Academy of Ophthalmology suggests cleaning the eyelid margins with mild soap or commercial eyelid cleansers, and performing gentle massage of the affected area after applying warm compresses to help express the obstructed gland 1, 2, 3
Second-Line Management
- The American Academy of Ophthalmology considers topical antibiotics for moderate to severe cases or when there are signs of spreading infection 1, 3
- Oral antibiotics are reserved for severe cases with spreading infection or systemic symptoms, as recommended by the American Academy of Ophthalmology 2, 3
Special Considerations
- The American Academy of Ophthalmology recommends a more aggressive eyelid hygiene regimen for recurrent hordeola, and evaluation for underlying conditions such as blepharitis or meibomian gland dysfunction 1, 2, 3, 4
- The American Academy of Ophthalmology suggests considering evaluation for possible sebaceous carcinoma in cases of marked asymmetry, resistance to therapy, or unifocal recurrent chalazia 1
Important Clinical Pearls
- The American Academy of Ophthalmology advises against squeezing or attempting to "pop" the hordeolum, as this may spread infection 2
- The American Academy of Ophthalmology recommends discontinuing eye makeup use during active infection 2, 4
- The American Academy of Ophthalmology suggests considering addressing moderate to severe blepharitis prior to intraocular surgical procedures to reduce risk of complications 3
Common Pitfalls
- The American Academy of Ophthalmology warns against failure to distinguish between hordeolum (acute infection) and chalazion (chronic, non-infectious inflammation) 2, 3
- The American Academy of Ophthalmology advises against missing underlying chronic blepharitis that predisposes to recurrent hordeola 1, 2
- The American Academy of Ophthalmology recommends considering sebaceous carcinoma in cases of recurrent unilateral disease resistant to therapy 1
Management of Persistent Hordeolum
Second-Line Management
- If no improvement is seen after 48 hours of appropriate therapy, consider modifying the treatment approach, as suggested by the American Academy of Ophthalmology 5
Risk Factors and Special Considerations in the Management of Hordeolum
Associations with Recurrent Hordeolum
- Bacterial blepharitis is the most common underlying condition linked to recurrent external hordeola. 6
- Meibomian gland dysfunction is frequently associated with repeated stye formation. 6
- Ocular rosacea is identified as a contributing factor in patients experiencing recurrent hordeola. 6
Pediatric Population
- Children who have previously developed a stye are at higher risk of later developing adult‑onset rosacea. 6
Immunocompromised Patients (Diabetes, HIV, Chemotherapy)
- Patients with compromised immune systems are prone to more aggressive eyelid infections and therefore require special clinical consideration. 7
- Systemic (oral) antibiotics may be necessary in addition to topical therapy for immunocompromised individuals with hordeolum. 7
- Aggressive manipulation of the eyelid (analogous to ear‑canal irrigation) should be avoided in diabetic or immunocompromised patients to reduce the risk of serious secondary infections. 7